期刊文献+

高尔基体蛋白73在原发性肝癌诊断中的意义

Significance of golgi protein 73 detection for diagnosis of primary hepatocellular carcinoma
原文传递
导出
摘要 目的探究高尔基体蛋白73在原发性肝癌中的表达水平及对早期诊断的意义。方法收集原发性肿癌(PHC)患者59例为观察组和健康体检者30例为对照组,分别采用酶联免疫吸附试验和化学发光免疫分析法测定两组患者血清GP73和甲胎蛋白(AFP)水平,比较两组间差异,进行统计学分析。结果 PHC患者体内GP73的表达不受年龄、性别、有无乙肝病毒携带、肿瘤大小、有无转移等因素影响,差异无统计学意义(P>0.05)。观察组患者血清中的GP73和AFP水平显著高于正常对照组,差异有统计学意义(P<0.05)。结论 GP73对原发性肝癌的早期诊断具有重要意义,联合AFP诊断更能提高原发性肝癌的诊出率。 Objective To observe the expression level of Golgi protein 73 in primary hepatocellular carcinoma and the significance for early diagnosis. Methods 59 primary hepatocellular carcinoma patients(PHC,group A)and 30 cases of healthy check-up(group B)were collected to observe the changes of GP73 and AFP levels by using methods of ELISA and chemiluminescence immunoassay,and compare the differences between the two groups for statistical analysis. Results The results showed that the levels of GP73 and AFP in group PHC were higher than the group B, and the difference had statistically significant(P〈0.05). The GP73 expression of PHC patients were not affected by age, gender, presence of hepatitis b virus carrying, tumor size, presence of transfer factors. Conclusion GP73 has the vital clinical significance to the early diagnosis for primary hepatocellular carcinoma.GP73 combined with AFP diagnosis can increase the diagnostic rate of primary hepatocellular carcinoma.
出处 《中国城乡企业卫生》 2016年第3期1-3,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
关键词 原发性肝癌 高尔基体蛋白73 早期诊断 Primary hepatocellular carcinoma Golgi Protein 73 Diagnosis value
  • 相关文献

参考文献10

二级参考文献25

  • 1Piotr Stefaniuk,Janusz Cianciara,Alicja Wiercinska-Drapalo.Present and future possibilities for early diagnosis of hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(4):418-424. 被引量:110
  • 2Amal Gad,Eiji Tanaka,Akihiro Matsumoto,Moushira Abd-el Wahab,Abd el-Hamid Serwah,Fawzy Attia,Khalil Ali,Howayda Hassouba,Abd el-Raoof el-Deeb,Tetsuya Ichijyo,Takeji Umemura,Hidetomo Muto,Kaname Yoshizawa,Kendo Kiyosawa.Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(42):6607-6612. 被引量:8
  • 3Charlotte E Ariyan,Ronald R Salem.Evolution in the treatment of metastatic colorectal carcinoma of the liver[J].World Journal of Gastroenterology,2006,12(20):3253-3258. 被引量:9
  • 4陈创,杨国梁,李雁,陈利琴.肿瘤标志物在胃癌诊断和监测中的价值和改进策略(附100例报告)[J].医学新知,2007,17(1):15-19. 被引量:6
  • 5Marrero JA, Romano PR, Nikolaeva 0,et al. GP73 , a residentGolgi glycoprotein, is a novel serum marker for hepatocellularcarcinoma. J Hepatol, 2005 ,43 : 1007-1012.
  • 6Kladney RD, Bulla GA, Guo L, et al. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene, 2000,249:53-65.
  • 7Block TM, Comunale MA, Lowman M,et al. Use of targetedglycoproteomics to identify serum glycoproteins that correlate withliver Cancer in woodchucks and humans. Proc Natl Acad SciUSA, 2005,102:779-784.
  • 8Schwegler EE, Cazares L, Steel LF, et al. SELDI-TOF MSprofiling of serum for detection of the progression of chronichepatitis C to hepatocellular carcinoma. Hepatology, 2005,41:634-642.
  • 9Riener MO,Stenner F,Liewen H, et al. Colgi phosphoprotein2(G0LPH2) expression in liver tumors and its value as a serummarker in hepatocellular carcinomas. Hepatology, 2009, 49:1602-1609.
  • 10Hu JS, Wu DW, Liang S,et al. GP73,a resident Golgiglycoprotein,is sensibility and specificity for hepatocellularcarcinoma of diagnosis in a hepatitis B-endemic Asianpopulation. Med Oncol, 2010,27 : 339-345.

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部